CY2421B1 - Nucleoside analogs in combination therapy of herpes simplex infections. - Google Patents

Nucleoside analogs in combination therapy of herpes simplex infections.

Info

Publication number: CY2421B1
Authority: CY; Cyprus
Prior art keywords: combination therapy; herpes simplex; nucleoside analogs; simplex infections; infections
Prior art date: 1996-01-26

Application number

CY0400005A

Other languages

English (en)

Inventor

Malcolm Richard Boyd

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-26

Filing date

2004-01-08

Publication date

2004-11-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10787583&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2421(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-01-08 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2004-11-12 Publication of CY2421B1 publication Critical patent/CY2421B1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

CY0400005A 1996-01-26 2004-01-08 Nucleoside analogs in combination therapy of herpes simplex infections. CY2421B1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9601544.1A GB9601544D0 (en)	1996-01-26	1996-01-26	Pharmaceuticals

Publications (1)

Publication Number	Publication Date
CY2421B1 true CY2421B1 (en)	2004-11-12

Family

ID=10787583

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CY0400005A CY2421B1 (en)	1996-01-26	2004-01-08	Nucleoside analogs in combination therapy of herpes simplex infections.

Country Status (25)

Country	Link
US (5)	US6514980B1 (fr)
EP (1)	EP0876146B1 (fr)
JP (1)	JP2000507211A (fr)
KR (1)	KR19990081966A (fr)
CN (1)	CN1133433C (fr)
AR (1)	AR005551A1 (fr)
AT (1)	ATE238796T1 (fr)
AU (1)	AU713202B2 (fr)
BR (1)	BR9707304A (fr)
CY (1)	CY2421B1 (fr)
CZ (1)	CZ297841B6 (fr)
DE (1)	DE69721484T2 (fr)
DK (1)	DK0876146T3 (fr)
ES (1)	ES2199339T3 (fr)
GB (1)	GB9601544D0 (fr)
HU (1)	HU226793B1 (fr)
IL (1)	IL125075A (fr)
NO (1)	NO316355B1 (fr)
NZ (1)	NZ326839A (fr)
PL (1)	PL187076B1 (fr)
PT (1)	PT876146E (fr)
TR (1)	TR199801439T2 (fr)
TW (1)	TW493985B (fr)
WO (1)	WO1997026882A1 (fr)
ZA (1)	ZA97608B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW438585B (en)	1995-02-06	2001-06-07	Astra Ab	Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
GB9601544D0 (en) *	1996-01-26	1996-03-27	Smithkline Beecham Plc	Pharmaceuticals
US7591945B2 (en) *	2003-02-07	2009-09-22	Gambro Lundia Ab	Support device for containers in extracorporeal blood treatment machines
JP2008536822A (ja) *	2005-03-25	2008-09-11	アルトソリューションズインコーポレーテッド	テロメラーゼ陽性細胞におけるテロメア長の調節および癌治療
EP1885370A4 (fr) *	2005-05-18	2012-07-25	Alt Solutions Inc	Modulation pharmacologique de la longueur telomerique dans des cellules cancereuses pour la prevention et le traitement de cancer
WO2011035120A2 (fr) *	2009-09-17	2011-03-24	Gk Ventures, L.L.C.	Composition thérapeutique pour traiter des lésions provoquées par le virus herpès simplex
GB201907305D0 (en) *	2019-05-23	2019-07-10	Douglas Pharmaceuticals Ltd	Treatment of conditions
CN112704154A (zh) *	2020-12-24	2021-04-27	中国人民解放军66399部队	一种用于治疗宠物猫疱疹病毒的营养膏

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3317384A (en) *	1964-06-08	1967-05-02	Upjohn Co	Treatment of topical viral infections with glucocorticoids and nucleosides
US3322627A (en) *	1964-09-03	1967-05-30	Merck & Co Inc	Method of treating herpes simplex infections with 5-methylamino-2'-deoxyuridine, and compositions therefor
GB9001886D0 (en) *	1990-01-26	1990-03-28	Beecham Group Plc	Pharmaceutical formulation
GB9015051D0 (en) *	1990-07-07	1990-08-29	Beecham Group Plc	Pharmaceutical treatment
ATE146075T1 (de)	1992-10-01	1996-12-15	Wellcome Found	Tucaresol als mittel zur immunopotentierung
GB9426021D0 (en)	1994-12-22	1995-02-22	Smithkline Beecham Plc	Pharmaceuticals
TW438585B (en) *	1995-02-06	2001-06-07	Astra Ab	Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
GB9601544D0 (en) *	1996-01-26	1996-03-27	Smithkline Beecham Plc	Pharmaceuticals
US6136835A (en) *	1999-05-17	2000-10-24	The Procter & Gamble Company	Methods of treatment for viral infections

1996
- 1996-01-26 GB GBGB9601544.1A patent/GB9601544D0/en active Pending
1997
- 1997-01-24 AT AT97901694T patent/ATE238796T1/de active
- 1997-01-24 ZA ZA97608A patent/ZA97608B/xx unknown
- 1997-01-24 AR ARP970100303A patent/AR005551A1/es not_active Application Discontinuation
- 1997-01-24 AU AU15506/97A patent/AU713202B2/en not_active Ceased
- 1997-01-24 IL IL12507597A patent/IL125075A/xx not_active IP Right Cessation
- 1997-01-24 ES ES97901694T patent/ES2199339T3/es not_active Expired - Lifetime
- 1997-01-24 BR BR9707304A patent/BR9707304A/pt not_active IP Right Cessation
- 1997-01-24 JP JP9526681A patent/JP2000507211A/ja active Pending
- 1997-01-24 DE DE69721484T patent/DE69721484T2/de not_active Expired - Fee Related
- 1997-01-24 CN CNB971918694A patent/CN1133433C/zh not_active Expired - Fee Related
- 1997-01-24 CZ CZ0234098A patent/CZ297841B6/cs not_active IP Right Cessation
- 1997-01-24 TR TR1998/01439T patent/TR199801439T2/xx unknown
- 1997-01-24 WO PCT/GB1997/000226 patent/WO1997026882A1/fr not_active Ceased
- 1997-01-24 EP EP97901694A patent/EP0876146B1/fr not_active Revoked
- 1997-01-24 KR KR1019980705684A patent/KR19990081966A/ko not_active Ceased
- 1997-01-24 PT PT97901694T patent/PT876146E/pt unknown
- 1997-01-24 DK DK97901694T patent/DK0876146T3/da active
- 1997-01-24 NZ NZ326839A patent/NZ326839A/en not_active IP Right Cessation
- 1997-01-24 HU HU9900945A patent/HU226793B1/hu not_active IP Right Cessation
- 1997-01-24 PL PL97327917A patent/PL187076B1/pl not_active IP Right Cessation
- 1997-02-26 TW TW086102357A patent/TW493985B/zh active
1998
- 1998-07-23 NO NO19983402A patent/NO316355B1/no not_active IP Right Cessation
2000
- 2000-07-26 US US09/626,015 patent/US6514980B1/en not_active Expired - Lifetime
2001
- 2001-06-19 US US09/884,715 patent/US20040185433A1/en not_active Abandoned
2004
- 2004-01-08 CY CY0400005A patent/CY2421B1/xx unknown
2005
- 2005-04-14 US US11/105,842 patent/US20050222016A1/en not_active Abandoned
2008
- 2008-07-02 US US12/217,193 patent/US20080287389A1/en not_active Abandoned
2010
- 2010-08-30 US US12/871,563 patent/US20100323952A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20080287389A1 (en)	2008-11-20
ATE238796T1 (de)	2003-05-15
DK0876146T3 (da)	2003-08-11
US20040185433A1 (en)	2004-09-23
CN1209748A (zh)	1999-03-03
AR005551A1 (es)	1999-06-23
EP0876146B1 (fr)	2003-05-02
DE69721484D1 (de)	2003-06-05
GB9601544D0 (en)	1996-03-27
CZ297841B6 (cs)	2007-04-11
US20100323952A1 (en)	2010-12-23
IL125075A (en)	2003-02-12
KR19990081966A (ko)	1999-11-15
DE69721484T2 (de)	2004-02-26
BR9707304A (pt)	1999-07-20
HU226793B1 (en)	2009-10-28
NO316355B1 (no)	2004-01-19
US20050222016A1 (en)	2005-10-06
CZ234098A3 (cs)	1999-02-17
NZ326839A (en)	2001-02-23
TW493985B (en)	2002-07-11
HK1016475A1 (en)	1999-11-05
JP2000507211A (ja)	2000-06-13
EP0876146A1 (fr)	1998-11-11
ES2199339T3 (es)	2004-02-16
WO1997026882A1 (fr)	1997-07-31
ZA97608B (en)	1998-07-24
PL187076B1 (pl)	2004-05-31
TR199801439T2 (xx)	1998-10-21
CN1133433C (zh)	2004-01-07
US6514980B1 (en)	2003-02-04
PT876146E (pt)	2003-09-30
HUP9900945A2 (hu)	1999-07-28
HUP9900945A3 (en)	2001-02-28
NO983402L (no)	1998-07-23
NO983402D0 (no)	1998-07-23
AU1550697A (en)	1997-08-20
AU713202B2 (en)	1999-11-25
PL327917A1 (en)	1999-01-04
IL125075A0 (en)	1999-01-26

Publication	Publication Date	Title
GB9413724D0 (en)	1994-08-24	Therapeutic nucleosides
AU4776393A (en)	1994-02-14	Dna encoding the human a1 adenosine receptor
GR3024699T3 (en)	1997-12-31	Use of dideoxy nucleoside analogues in the treatment of viral infections.
IL92587A0 (en)	1990-08-31	2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition
PL299412A1 (en)	1993-12-27	Novel purine nucleosides, novel intermediate compounds and pharmaceutical preparation
CY2421B1 (en)	2004-11-12	Nucleoside analogs in combination therapy of herpes simplex infections.
AU4508493A (en)	1994-01-31	Therapeutic nucleosides
GB9200150D0 (en)	1992-02-26	Therapeutic nucleosides
SI0876146T1 (en)	2004-02-29	Nucleoside analogs in combination therapy of herpes simplex infections
HU9503135D0 (en)	1996-01-29	Method of combating acyclovir-resistant herpes simplex viral infections
GB9514268D0 (en)	1995-09-13	Pyrimidine nucleoside
ZA968439B (en)	1997-11-21	Purine and guanine compounds.
ZA941243B (en)	1995-08-23	Antiviral therapy
GB9606264D0 (en)	1996-05-29	Pyrimidine nucleoside derivatives
GB9307012D0 (en)	1993-05-26	Therapeutic nucleosides
GB9302031D0 (en)	1993-03-17	Therapeutic nucleosides
GB9322988D0 (en)	1994-01-05	Therapeutic nucleosides
GB9614024D0 (en)	1996-09-04	Antiviral therapeutic combinations
GB9614022D0 (en)	1996-09-04	Antiviral therapeutic combinations
GB9220156D0 (en)	1992-11-04	Therapeutic nucleosides
GB9203307D0 (en)	1992-04-01	Therapeutic nucleosides
GB9214172D0 (en)	1992-08-12	Therapeutic nucleosides
GB9214171D0 (en)	1992-08-12	Therapeutic nucleosides
GB9214170D0 (en)	1992-08-12	Therapeutic nucleosides
GB9208017D0 (en)	1992-05-27	Therapeutic nucleosides